MedTrace Logo

Safer Cycling in Older Age

NCT04362514 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 127

Last updated 2024-12-06

No results posted yet for this study

Summary

The aim of the SiFAr-project is to increase safe cycling in community-dwelling older adults (age 65 years and older) with a structured, multi-component exercise cycling training. The progressive exercise program encompasses training of motor competence and cognitive functions. The ability to cycle safely will be tested prior and after the training period using a cycling course, which consists of variant tasks requiring motor and cognitive skills.

Conditions

  • Older Adults
  • Community-dwelling
  • Cycling Competence

Interventions

BEHAVIORAL

MEPC - Multi-component exercise program related to cycling

Structured and progressive multicomponent exercise program with and without bikes. Training period will last over 3 months with 8 sessions à 60 minutes. Training sessions will address motor competence (balance, strength, cycling skills and techniques) and cognitive skills required during cycling. Furthermore, fall-related psychological concerns will be addressed.

OTHER

HRP - health-related presentations

HRP include 3 presentations on healthy aging (one per month) with a duration of 60 minutes

Sponsors & Collaborators

  • ADAC (The General German Automobile Club) foundation

    collaborator UNKNOWN

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Robert Kob, PhD · Institute for Biomedicine of Aging

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2022-11-01
Completion
2022-12-05

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04362514 on ClinicalTrials.gov